Jaudszus Anke, Foerster Martin, Kroegel Claus, Wolf Ingrid, Jahreis Gerhard
Institute of Nutrition, Friedrich Schiller University of Jena, Dornburger Str. 24, D-07743 Jena, Germany.
Biochim Biophys Acta. 2005 Dec 15;1737(2-3):111-8. doi: 10.1016/j.bbalip.2005.11.001. Epub 2005 Nov 9.
Interaction of eosinophils and bronchial epithelial cells plays a pivotal role in maintaining inflammatory airway disease. Since conjugated linoleic acids (CLA) are suggested to exert anti-inflammatory effects, one purpose of this study was to compare cis-9,trans-11-CLA and trans-10,cis-12-CLA with regard to their influence on the stimulus-induced activation of eosinophils. ECP (eosinophil cationic protein) released in co-culture of stimulated and CLA-treated eosinophils with stimulated bronchial epithelial cells (BEAS-2B) was measured and cis-9,trans-11-CLA was found to be most potent in inhibiting ECP formation. Further, expression of the activation markers CD69 and CD13 induced by various stimuli (TNF-alpha, IL-5, IL-3) was significantly reduced in the presence of cis-9,trans-11-CLA. Subsequently, various concentrations of cis-9,trans-11-CLA vs. linoleic acid (LA, cis-9,cis-12-octadecadienoic acid) were tested for the effect on proliferative response and release of the pro-inflammatory cytokine IL-8 in stimulated BEAS-2B. Addition of cis-9,trans-11-CLA attenuated cell growth and significantly reduced IL-8 production at mRNA and protein levels. In contrast, LA had a slight stimulating effect on proliferation and was less effective in reducing the cytokine release. It was demonstrated that the inhibitory effect of cis-9,trans-11-CLA on IL-8 production is mediated through activation of the nuclear receptor PPARgamma, since blocking the receptor with a selective antagonist (GW9662) restored the stimulus-induced enhancement in IL-8 mRNA expression and protein secretion. PPARgamma has previously been shown to be closely involved in the downregulation of inflammation during hyperresponsiveness related to pulmonary immune responses. Thus, targeting PPARgamma, cis-9,trans-11-CLA might be of therapeutic value in the focus of airway disease while ameliorating inflammatory processes by affecting epithelial and eosinophil functions.
嗜酸性粒细胞与支气管上皮细胞的相互作用在维持气道炎症性疾病中起关键作用。由于共轭亚油酸(CLA)被认为具有抗炎作用,本研究的一个目的是比较顺式-9,反式-11-CLA和反式-10,顺式-12-CLA对刺激诱导的嗜酸性粒细胞活化的影响。测定了经刺激的CLA处理的嗜酸性粒细胞与刺激的支气管上皮细胞(BEAS-2B)共培养时释放的嗜酸性粒细胞阳离子蛋白(ECP),发现顺式-9,反式-11-CLA在抑制ECP形成方面最有效。此外,在存在顺式-9,反式-11-CLA的情况下,由各种刺激(TNF-α、IL-5、IL-3)诱导的活化标志物CD69和CD13的表达显著降低。随后,测试了不同浓度的顺式-9,反式-11-CLA与亚油酸(LA,顺式-9,顺式-12-十八碳二烯酸)对刺激的BEAS-2B增殖反应和促炎细胞因子IL-8释放的影响。添加顺式-9,反式-11-CLA可减弱细胞生长,并在mRNA和蛋白质水平上显著降低IL-8的产生。相比之下,LA对增殖有轻微的刺激作用,在减少细胞因子释放方面效果较差。结果表明,顺式-9,反式-11-CLA对IL-8产生的抑制作用是通过核受体PPARγ的激活介导的,因为用选择性拮抗剂(GW9662)阻断该受体可恢复刺激诱导的IL-8 mRNA表达和蛋白质分泌的增强。PPARγ先前已被证明与肺免疫反应相关的高反应性期间炎症的下调密切相关。因此,靶向PPARγ,顺式-9,反式-11-CLA可能在气道疾病的治疗中具有价值,同时通过影响上皮细胞和嗜酸性粒细胞功能来改善炎症过程。